Khosla Ventures Acquisition Co
Change company Symbol lookup
Select an option...
KVSA Khosla Ventures Acquisition Co
FPI Farmland Partners Inc
HNST Honest Company Inc
ATAI ATAI Life Sciences NV
FTS Fortis Inc
VLO Valero Energy Corp
BBLN+ Babylon Holdings Equity Warrants 21st Oct 2026 *W EXP 10/21/2026
NEGG Newegg Commerce Inc

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Company profile

Khosla Ventures Acquisition Co. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus its search on market opportunity with differentiated, proprietary technology. The Company has not commenced any operations and has not generated revenues.

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

U.S. to pay Moderna $1.7 billion for 66 million doses of a new COVID-19 vaccine booster

8:17 am ET July 29, 2022 (MarketWatch)

Shares of Moderna Inc. (MRNA) gained 3.8% in premarket trading on Friday after the company said the U.S. will buy 66 million doses of a bivalent COVID-19 booster candidate that can better protect against the BA.5 strain. That vaccine is not yet in clinical trials but studies are expected to begin "in the near future," a Moderna spokesperson told MarketWatch earlier this week. The U.S. government will pay up to $1.74 billion to Moderna to produce and deliver 66 million doses of the booster candidate. There is also an option for the U.S. to purchase up to 234 million doses of COVID-19 booster candidates developed by Moderna. Both Moderna and Pfizer are developing bivalent boosters that equally target the original strain of the virus and the BA.4 and BA.5 variants. Moderna's stock is down 37.7% this year, while the broader S&P 500 has declined 14.5%.

-Jaimy Lee


(END) Dow Jones Newswires

July 29, 2022 08:17 ET (12:17 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.